As the UK begins life after Brexit, Wellcome's Director Jeremy Farrar sets out what the transition period and beyond could mean for research.
The commitment to research during the last two Ebola outbreaks has changed the course of this disease. Jeremy Farrar reflects on what made this possible.
The licensing of the first Ebola vaccine is a great achievement for the global healthcare community. What made it possible, and what lessons can we use to prevent and control future outbreaks?
It's a year since the Ebola outbreak in the Democratic Republic of the Congo began. If we want to prevent future outbreaks lasting a year, the world needs to address research gaps.
Wellcome is working with the UK Department for International Development in a five-year initiative to help prevent future epidemics and improve the response to current ones.
Wellcome is making £2 million available to the WHO and government of DRC to support vaccine research as part of the emergency response to the Ebola outbreak.
Developing new vaccines is challenging, costly and complex. CEPI is a new model for funding vaccine development which aims to change this.
If we put research at the heart of epidemic response, it’s a double win – helping fight outbreaks that are underway and protecting us in the future.